Ogawa, Wataru http://orcid.org/0000-0002-0432-4366
Araki, Eiichi
Ishigaki, Yasushi
Hirota, Yushi
Maegawa, Hiroshi
Yamauchi, Toshimasa
Yorifuji, Tohru
Katagiri, Hideki
Article History
Received: 8 December 2021
First Online: 31 January 2022
Declarations
:
: Wataru Ogawa: Lecture fee (Sumitomo Dainippon Pharma Co., Ltd., Novartis Pharma K.K., Nippon Boehringer Ingelheim Co., Ltd., Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Abbott Japan), Total amount of research expenses (joint research, commissioned research, clinical trials, etc.) and grants (Noster, Nippon Boehringer Ingelheim Co., Ltd., Boehringer Ingelheim Pharma GmbH&Co.KG, Eli Lilly Japan K.K., Novo Nordisk Pharma LTD., Abbott Japan, Abbott Diabetes Care UK Ltd, Sumitomo Dainippon Pharma Co., Ltd.), Total amount of scholarships (incentives) (Kowa Company, Ltd., Novo Nordisk Pharma LTD., Astellas Pharma Inc., Sumitomo Dainippon Pharma Co., Ltd., ONO PHARMACEUTICAL CO., LTD., Takeda Pharmaceutical Co. Ltd., Abbott Japan, Novartis Pharma K.K., DAIICHI SANKYO CO., LTD., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corporation, Nippon Boehringer Ingelheim Co., Ltd.), Eiichi Araki: Lecture fees (AstraZeneca, MSD, ONO PHARMACEUTICAL CO., LTD., Kowa Company, Ltd., Sanofi, DAIICHI SANKYO CO., LTD., Sumitomo Dainippon Pharma Co., Ltd., Novo Nordisk Pharma LTD.) Total amount of scholarships (incentives) (Astellas Pharma Inc., Kowa Company, Ltd., Sanofi, DAIICHI SANKYO CO., LTD., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Nippon Boehringer Ingelheim Co., Ltd., Eli Lilly Japan K.K., Novartis Pharma K.K., Novo Nordisk Pharma LTD. Bayer Yakuhin Ltd) Endowed chair (ONO PHARMACEUTICAL CO., LTD., Terumo Corporation), Yasushi Ishigaki: Lecture fees (MSD, Novartis Pharma K.K., Mitsubishi Tanabe Pharma Corporation, Sanofi, ONO PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Co. Ltd., Novo Nordisk Pharma LTD.) Total amount of research expenses (joint research, commissioned research, clinical trials, etc.) and grants (Novo Nordisk Pharma LTD., DAIICHI SANKYO CO., LTD.), Total amount of scholarships (incentives) donations (Novartis Pharma K.K., ONO PHARMACEUTICAL CO., LTD., Takeda Science Foundation), Yushi Hirota: Lecture fee (Eli Lilly Japan K.K. Sanofi), Hiroshi Maegawa: Lecture fees (Sanofi, Nippon Boehringer Ingelheim Co., Ltd., Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma LTD., Sumitomo Dainippon Pharma Co., Ltd., MSD, Astellas Pharma Inc., DAIICHI SANKYO CO., LTD., AstraZeneca, Eli Lilly Japan K.K.) Total amount of research fees (joint research, commissioned research, clinical trials, etc.) and grants (Nippon Boehringer Ingelheim Co., Ltd., Sunstar, Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co., Ltd. And Cimic Co., Ltd., Nissan Chemical Corporation, MIKI Corporation, Parexel), Total amount of scholarships (incentives) (Takeda Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co., Ltd., Mitsubishi Tanabe Pharma Corporation, DAIICHI SANKYO CO., LTD., Sumitomo Dainippon Pharma Co., Ltd., Kowa Company, Ltd., Sanwa Kagakukenkyusho Co, Ltd., Novo Nordisk Pharma LTD., Nipro Corporation, Astellas Pharma Inc., MSD, Taisho Pharma Co., Ltd., ONO PHARMACEUTICAL CO., LTD., Bayer Yakuhin Ltd, Novartis Pharma K.K.), Toshimasa Yamauchi: Lecture fees (Astellas Pharma Inc., AstraZeneca, ONO PHARMACEUTICAL CO., LTD., Sanofi, Takeda Pharmaceutical Co. Ltd., DAIICHI SANKYO CO., LTD., Novartis Pharma K.K., Novo Nordisk Pharma LTD.), Total amount of research expenses (joint research, commission research, clinical trials, etc.) and grants (Astra Zeneca, Kowa Company, Ltd., MSD, DAIICHI SANKYO CO.,LTD., Sanofi, Nippon Boehringer Ingelheim Co.,Ltd., Aero Switch Therapeutics, Inc., Sanwa Kagakukenkyusho Co, Ltd., Minophagen Pharmaceutical Co., LTD., Mitsubishi Corporation Life Sciences Limited, Nipro Corporation), Total amount of scholarships (incentives)(Kissei Pharmaceutical Co., Ltd., Taisho Pharma Co., Ltd., Kowa Company, Ltd., Kyowa Kirin Co., Ltd., Sanofi, Astellas Pharma Inc., Sumitomo Dainippon Pharma Co., Ltd., Novo Nordisk Pharma LTD., ONO PHARMACEUTICAL CO., LTD., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co. Ltd., Sanwa Kagakukenkyosho Co, Ltd.), Endowed chair offered by companies, etc. (Takeda Pharmaceutical Co. Ltd., ONO PHARMACEUTICAL CO., LTD., Novo Nordisk Pharma LTD., Mitsubishi Tanabe Pharma Corporation, MSD, Nippon Boehringer Ingelheim Co.,Ltd., Kowa Company, Ltd., NTT Docomo Inc., Asahi Mutual Life Insurance Co), Tohru Yorifuji: Lecture fees (Novo Nordisk Pharma LTD.), Hideki Katagiri: Lecture fees (Mitsubishi Tanabe Pharma Corporation, Sanofi, Novo Nordisk Pharma LTD.), Total amount of research expenses (joint research, commission research, clinical trials, etc.) and grants (Otsuka Pharmaceutical Co., Ltd., Suntory Holdings Limited, Astellas Pharma Inc.), Total amount of scholarships (incentives) donations (Takeda Pharmaceutical Co. Ltd., DAIICHI SANKYO CO., LTD., Novartis Pharma K.K., Mitsubishi Tanabe Pharma Corporation, ONO PHARMACEUTICAL CO., LTD., Eli Lilly Japan K.K., MSD., Sanofi., Novo Nordisk Pharma LTD.)
: This article does not contain any studies with human or animal subjects performed by any of the authors.